Maximillian Stahl

10PUBLICATIONS
78CO-AUTHORS
Regenerative medicine (incl. stem cells)Proteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Aug 18, 2026
Quantitation of Cirtuvivint (SM08502) in Human Plasma by LC-MS/MS.

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

|Oct 07, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.

Marlise R Luskin, Mark A Murakami, Julia Keating

|Jan 03, 2023
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.

Shai Shimony, Maximilian Stahl, Richard M Stone

|Sep 02, 2020
Interferon alpha therapy in essential thrombocythemia and polycythemia vera-a systematic review and meta-analysis.

Jan Philipp Bewersdorf, Smith Giri, Rong Wang

Pageof 2

Frequent Collaborators

3 joint publications

Richard M Stone

2 joint publications

Amer M Zeidan

2 joint publications

Daniel J DeAngelo

2 joint publications

Eunice S Wang